Work

A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.754.754

Authors: Elizabeth Hexner, Judith D. Goldberg, Josef T. Prchal, Erin P Demakos, Sabina Swierczek, Rona Singer Weinberg, Joseph Tripodi, Vesna Najfeld, Martin Carroll, Roberto Marchioli, Lewis R. Silverman, Ronald Hoffman

Institutions: University of Pennsylvania, New York University, University of Utah, New York Blood Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mario Negri Sud Foundation

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980055111

FWCI: 4.197

Cites:

Cited by: 32

Related to: 10